WO2005007116A3 - Systemes de cellules presentant l'antigene artificielles - Google Patents
Systemes de cellules presentant l'antigene artificielles Download PDFInfo
- Publication number
- WO2005007116A3 WO2005007116A3 PCT/US2004/022919 US2004022919W WO2005007116A3 WO 2005007116 A3 WO2005007116 A3 WO 2005007116A3 US 2004022919 W US2004022919 W US 2004022919W WO 2005007116 A3 WO2005007116 A3 WO 2005007116A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antigen presenting
- presenting cell
- artificial antigen
- cell devices
- aapc
- Prior art date
Links
- 210000000612 antigen-presenting cell Anatomy 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000770 proinflammatory effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48864103P | 2003-07-18 | 2003-07-18 | |
US60/488,641 | 2003-07-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005007116A2 WO2005007116A2 (fr) | 2005-01-27 |
WO2005007116A3 true WO2005007116A3 (fr) | 2006-12-14 |
Family
ID=34079444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/022919 WO2005007116A2 (fr) | 2003-07-18 | 2004-07-16 | Systemes de cellules presentant l'antigene artificielles |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005007116A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1736482A1 (fr) * | 2005-06-20 | 2006-12-27 | INSERM (Institut National de la Santé et de la Recherche Medicale) | Ligand recombinant trimeric de 4-1BB |
EP2025747A1 (fr) * | 2007-08-14 | 2009-02-18 | TumorTec GmbH | Procédé d'amplification in vitro de lymphocytes T-régulateurs |
KR101644984B1 (ko) * | 2011-12-22 | 2016-08-12 | 재단법인 목암생명과학연구소 | 자연살해세포의 제조방법, 이러한 방법에 의해 제조된 자연살해세포 및 이를 포함하는 종양 및 감염성 질환 치료용 조성물 |
KR101697473B1 (ko) | 2014-11-26 | 2017-01-18 | 주식회사 녹십자랩셀 | T 세포를 이용한 자연살해세포의 배양방법 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994029436A1 (fr) * | 1993-06-04 | 1994-12-22 | The United States Of America Represented By The Secretary Of The Navy | Procedes de stimulation selective de la proliferation des lymphocytes t |
WO1997005239A1 (fr) * | 1995-07-25 | 1997-02-13 | Celltherapy, Inc. | Immunotherapie par cellules autologues: compositions cellulaires , methodes et application au traitement d'une maladie humaine |
-
2004
- 2004-07-16 WO PCT/US2004/022919 patent/WO2005007116A2/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994029436A1 (fr) * | 1993-06-04 | 1994-12-22 | The United States Of America Represented By The Secretary Of The Navy | Procedes de stimulation selective de la proliferation des lymphocytes t |
WO1997005239A1 (fr) * | 1995-07-25 | 1997-02-13 | Celltherapy, Inc. | Immunotherapie par cellules autologues: compositions cellulaires , methodes et application au traitement d'une maladie humaine |
Non-Patent Citations (2)
Title |
---|
SCHAFER P.H. ET AL.: "P38alpha mitogen-activated protein kinase is activated by CD28-mediated signaling and is required for IL-4 production by human CD4+Cd45RO+ T cells and Th2 effector cells", J. OF IMMUNOLOGY, vol. 162, 1999, pages 7110 - 7119, XP002966702 * |
SWANSON M.A. ET AL.: "IFN-gamma Production by Th1 Cells Generated from Naive CD4+ T Cells Exposed to Norepinephrine", JOURNAL OF IMMUNOLOGY, vol. 166, 2001, pages 232 - 240, XP003004913 * |
Also Published As
Publication number | Publication date |
---|---|
WO2005007116A2 (fr) | 2005-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1266959A3 (fr) | Anlage und verfahren zur gewinnen von zellen | |
AU2003209259A1 (en) | Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof | |
WO2005002621A3 (fr) | Methodes visant a eliciter, ameliorer et maintenir des reponses immunitaires dirigees contre des epitopes restreints du cmh de classe i, a des fins prophylactiques ou therapeutiques | |
WO2007067782A3 (fr) | Compositions et procédés permettant d'induire l'activation de cellules dendritiques monocytiques immatures | |
HUE038833T2 (hu) | Antigénspecifikus T-sejtek létrehozása | |
TW200517126A (en) | Mesothelioma therapeutic agent | |
PL1648507T3 (pl) | Metody i kompozycje powodujące zwiększenie skuteczności przeciwciał terapeutycznych z użyciem związków wzmacniających działanie komórek nk | |
HK1079989A1 (en) | Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response | |
NO20062709L (no) | Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller | |
WO2006090291A3 (fr) | Procede | |
DK1553832T3 (da) | Præparater og fremgangsmåder til celleseparering | |
WO2007013893A3 (fr) | Compositions immunogenes contenant un antigene de l'anthrax, des microparticules de polymeres biodegradables, et un adjuvant immunologique contenant un polynucleotide | |
WO2007028079A3 (fr) | Procedes de stimulation de l'expansion de cellules souches hematopoietiques | |
AU2003251898A1 (en) | Device and methods for isolating target cells | |
WO2005007116A3 (fr) | Systemes de cellules presentant l'antigene artificielles | |
EP3031470A3 (fr) | Manipulation de cellules t régulatrices et fonction cc par ciblage de gènes de neuritine utilisant des anticorps, des agonistes et des antagonistes | |
WO2003063801A3 (fr) | Traitement de cellules tumorales destinees a l'immunotherapie du cancer | |
AU2003274429A1 (en) | Method and system for improving efficiency of fuel cell in portable devices | |
WO2003038062A3 (fr) | Generation et utilisation de cellules tc1 et tc2 | |
AU2003209297A1 (en) | Methods and compositions for preserving the viability of photoreceptor cells | |
AU4642600A (en) | Methods and compositions for use in potentiating antigen presentation by antigenpresenting cells | |
AU2003224313A1 (en) | Mycobacterial antigens and uses thereof | |
AU2003287521A1 (en) | Pluripotent cells from monocytes, and methods of making and using pluripotent cells | |
WO2005056763A3 (fr) | Procede et formulation pour l'amelioration de la viabilite de cellules et de tissu stockes | |
AU2003213640A1 (en) | Methods of modulating dendritic cells using adjuvants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |